ResearcherUniversity of Mississippi Medical CenterActive in the last 2 years
Kunwar Somesh Vikramdeo
Matched on ORCID iD 0000-0002-6016-2672; OpenAlex author ID A5062867891. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 4
- MYB and HIF1α crosstalk drives hypoxia-induced transcriptional reprogramming and adaptive signaling alterations in pancreatic cancer. First author DOI 10.1016/j.canlet.2025.217916↗
- Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mitochondrial Protein Import and Function. First author DOI 10.1158/1541-7786.mcr-23-0138↗
- MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. Co-author DOI 10.15252/embr.202255643↗
- Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential diagnostic applications in pancreatic aden… Co-author DOI 10.1038/s41598-022-22006-5↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Seema Singh · 4 shared papers, 2022–2025 · strength 0.90
- Paper MYB and HIF1α crosstalk drives hypoxia-induced transcriptional reprogramming and adaptive signaling alterations in panc… DOI 10.1016/j.canlet.2025.217916↗
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. DOI 10.15252/embr.202255643↗
- Shashi Anand · 4 shared papers, 2022–2025 · strength 0.90
- Paper MYB and HIF1α crosstalk drives hypoxia-induced transcriptional reprogramming and adaptive signaling alterations in panc… DOI 10.1016/j.canlet.2025.217916↗
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. DOI 10.15252/embr.202255643↗
- Mohammad Aslam Khan · 4 shared papers, 2022–2025 · strength 0.90
- Paper MYB and HIF1α crosstalk drives hypoxia-induced transcriptional reprogramming and adaptive signaling alterations in panc… DOI 10.1016/j.canlet.2025.217916↗
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. DOI 10.15252/embr.202255643↗
- Ajay P. Singh · 3 shared papers, 2022–2024 · strength 0.57
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. DOI 10.15252/embr.202255643↗
- Paper Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential di… DOI 10.1038/s41598-022-22006-5↗
- Santanu Dasgupta · 2 shared papers, 2022–2024 · strength 0.39
- Paper Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mit… DOI 10.1158/1541-7786.mcr-23-0138↗
- Paper Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential di… DOI 10.1038/s41598-022-22006-5↗
- Ajay Pratap Singh · 1 shared paper, 2025 · strength 0.33
- Mary Oluwadamilola Haastrup · 1 shared paper, 2024 · strength 0.23
- Sanjeev K. Srivastava · 1 shared paper, 2023 · strength 0.18
- Shafquat Azim · 1 shared paper, 2023 · strength 0.18
- Sachin Kumar Deshmukh · 1 shared paper, 2023 · strength 0.18
- Moh'd M. Khushman · 1 shared paper, 2022 · strength 0.16
- Martin J. Heslin · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.